We read with interest the report by Sattar and colleagues 1 that shows no significant relationship of plasma adiponectin levels with risk of coronary heart disease in the British Regional Heart Study. In a summary of published studies, Sattar et al 1 also report only a modest inverse association. However, we have concerns about their pooling of only a few studies when several different methodologies, populations, and analysis methods were used. For example, the Health Professionals Follow-Up Study was the only study that had blood specimens stored in liquid nitrogen at temperatures ϽϪ130°C. 2 Adiponectin was significantly inversely associated with coronary heart disease risk in the Health Professionals Follow-Up Study. 2 In the British Regional Heart Study, in which serum was stored for approximately 16 years at Ϫ20°C, reported adiponectin levels were considerably lower, and correlations of adiponectin with high-density lipoprotein cholesterol (rϭ0.33) and triglycerides (rϭϪ0.25) were substantially weaker as compared with the Health Professionals Follow-Up Study (rϭ0.44; rϭϪ0.39). The body mass index levels between the 2 studies were similar, but the correlations with body mass index were also weaker, even though body mass index was measured in the British Regional Heart Study (rϭϪ0.21) but self-reported in the Health Professionals Follow-Up Study (rϭϪ0.27). Therefore, additional data are required to better understand the impact of blood storage methods and characteristics on levels of adiponectin.
